It is argued that the value of genomic medicine for rare disease should be assessed beyond diagnostic yield alone and across individual, clinical and societal levels.
Abstract
ABSTRACT The United Nations, 2021 resolution to promote and protect the human rights of the estimated 300 million People Living with a Rare Disease and their families, set a milestone worldwide. At the same time, the successful diagnostic results of large genomic initiatives are reshaping rare disease healthcare in many countries. However, increasing diagnostic capability does not necessarily translate into improved care. Patients, families, and healthcare professionals navigate challenges in variant interpretation and prognosis, uneven access to specialist expertise and follow‐up, limited natural history information and therapeutic options, and the wider familial and reproductive implications of genomic findings. Healthcare systems also face challenges related to workforce and service capacity, data governance, equity, research sustainability, and the integration of genomic technologies into longitudinal care. Drawing on published evidence, patient‐organization experience and illustrative clinical scenarios, we argue that the value of genomic medicine for rare disease should be assessed beyond diagnostic yield alone and across individual, clinical and societal levels. Our vision for the future includes accessible education for families and professionals, multidisciplinary and longitudinal rare disease services embedded within publicly funded healthcare, sustainable research and data‐sharing frameworks, partnership with patient advocacy organizations, and meaningful representation of people living with rare disease in governance, research, and innovation.
This perspective paper outlines the conceptual foundations of the INFORM-RD research project (a patient-informed clinical platform to inform patient-centred decision-making for rare diseases), embedded at KU Leuven, Leuven Institute for Rare Diseases and University Hospitals Leuven, Belgium.
K. Demesure, Lien Beckers, Wendy Vansteenkiste et al.· Therapeutic Advances in Rare...· 0 citations
Rare diseases affect over 400 million people worldwide and present a major opportunity for health system reform. Primary mitochondrial disease comprises progressive, genetically heterogeneous disorders caused by pathogenic variants in mitochondrial or nuclear DNA, with an estimated prevalence of 1 in 4300 and likely un...
Amanda Temby, R. Stefanetti, Lyndsey Butterworth et al.· BMJ Innovations· 0 citations
This book examines the phenomenon of overdiagnosis and its implications for contemporary healthcare systems. It analyses how advances in diagnostics, screening technologies, and preventive medicine have increased the capacity to detect disease while also creating the risk of identifying conditions that would never ca...
Alexandra Brandt Ryborg Jønsson, John Brandt Brodersen· 0 citations
Approximately 7,000 rare diseases collectively affect an estimated 300 million people worldwide, yet fewer than 5 percent of these conditions have an approved therapy. Drug development for rare neurological and neurodevelopmental disorders presents unique ethical challenges that distinguish it from clinical research...
K. Olugemo, Joseph P. Horrigan, Joan Busner et al.· Orphanet Journal of Rare Dis...· 0 citations
Rare diseases collectively affect over 300 million individuals globally, yet their epidemiology remains inadequately characterised, particularly in low- and middle-income countries. In India, epidemiological gaps arise from fragmented data systems, diagnostic odyssey, and limited integration of clinical and genomic inf...
A. Mittal, Mamta Patel, D. S. Shekhawat et al.· The Indian journal of medica...· 0 citations
Whole-genome sequencing is increasingly emerging as a first-line genomic strategy for pediatric rare diseases, while complementary technologies, expert phenotyping, and iterative data interpretation remain essential for comprehensive and accurate diagnosis and equitable access to genomic medicine.
Natàlia Caelles-Gramunt, J. Pijuan· Children· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.